GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HES1 | hg38_v1_chr3_+_194136138_194136155 | -0.18 | 8.3e-03 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_-_13814490 Show fit | 35.59 |
ENST00000379170.8
|
mitochondrial calcium uniporter regulator 1 |
|
chr9_+_89311187 Show fit | 27.36 |
ENST00000314355.7
|
CDC28 protein kinase regulatory subunit 2 |
|
chr2_-_10448318 Show fit | 26.54 |
ENST00000234111.9
|
ornithine decarboxylase 1 |
|
chr1_+_165827786 Show fit | 22.41 |
ENST00000642653.1
|
uridine-cytidine kinase 2 |
|
chr1_+_165827574 Show fit | 20.26 |
ENST00000367879.9
|
uridine-cytidine kinase 2 |
|
chrX_+_21940693 Show fit | 18.67 |
ENST00000404933.7
ENST00000379404.5 |
spermine synthase |
|
chr3_+_184363427 Show fit | 18.46 |
ENST00000429568.1
|
RNA polymerase II, I and III subunit H |
|
chr3_+_184363387 Show fit | 18.37 |
ENST00000452961.5
|
RNA polymerase II, I and III subunit H |
|
chr3_+_184363351 Show fit | 17.10 |
ENST00000443489.5
|
RNA polymerase II, I and III subunit H |
|
chr1_+_220094086 Show fit | 17.02 |
ENST00000366922.3
|
isoleucyl-tRNA synthetase 2, mitochondrial |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 69.3 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
10.7 | 42.7 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
8.2 | 41.2 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
2.4 | 41.0 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
4.8 | 38.7 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.8 | 36.9 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.3 | 33.5 | GO:0006414 | translational elongation(GO:0006414) |
0.9 | 26.0 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
1.1 | 25.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.8 | 24.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 84.1 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
4.0 | 64.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 51.8 | GO:0016607 | nuclear speck(GO:0016607) |
0.9 | 51.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 43.1 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
1.3 | 38.7 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
3.3 | 36.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.2 | 34.8 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 34.4 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.6 | 32.0 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 64.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.7 | 47.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
6.1 | 42.7 | GO:0004849 | uridine kinase activity(GO:0004849) |
6.8 | 41.0 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
3.4 | 36.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.8 | 35.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
2.7 | 35.2 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.2 | 35.2 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.7 | 34.0 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
6.3 | 31.7 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 95.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
1.0 | 36.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.7 | 29.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 29.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.3 | 18.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.4 | 17.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 16.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.4 | 15.3 | PID ATR PATHWAY | ATR signaling pathway |
0.4 | 14.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 14.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 92.3 | REACTOME TRANSLATION | Genes involved in Translation |
3.1 | 64.4 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
3.2 | 63.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
1.5 | 58.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.4 | 49.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.5 | 47.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
3.4 | 37.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.5 | 30.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 28.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.5 | 27.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |